• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Exact Sciences

Phillips-Medisize, Exact Sciences to collaborate on colorectal cancer screening

November 3, 2021 By Sean Whooley

Phillips-Medisize and Exact Sciences (NSDQ:EXAS) today announced a collaboration to advance early cancer detection. The collaboration centers around Exact Sciences’ Cologuard, the first and only FDA-approved, non-invasive stool DNA screening test for colorectal cancer, according to a news release. Phillips-Medisize, a Molex company, said the collaboration will seek to focus on the patient experience through […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: Exact Sciences, Phillips-Medisize

The 10 most popular DeviceTalks Weekly Podcast episodes of 2020

December 31, 2020 By Tom Salemi

Without the ability to gather for events and meetings, the DeviceTalks team launched the DeviceTalks Weekly Podcast to keep our medtech community talking. Over the span of 9 months and 39 episodes, we interviewed dozens of medtech leaders from startups to multinational corporations to hear how they’re managing through the challenges of 2020. Our episodes […]

Filed Under: Featured Tagged With: Abbott Laboratories, Ambu, BD, becton dickinson, Becton Dickonson, Boston Scientific, Checkable Medical, Corindus, DHL Supply Chain, Edwards Lifesciences, Exact Sciences, Intuitive Surgical, MDMA, Medtronic, Novant Health, Outset Medical, Philips, Stryker, Thrive Earlier Detection Corp.

MedTech 100 roundup: Stocks continue to plummet

November 2, 2020 By Sean Whooley

Stocks in the medtech industry hit a wall two weeks ago, and it’s been a quick drop for them ever since. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 91.01 (Oct. 30), marking a 6.4% drop from the 97.02 points registered at the end […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: coronavirus, COVID-19, Exact Sciences, MedTech 100 Index, Medtronic, ResMed, Stryker, Teleflex, Thrive Earlier Detection Corp.

Exact Sciences to acquire Thrive for $2.15B

October 27, 2020 By Sean Whooley

Exact Sciences (NSDQ:EXAS) announced today that it is acquiring cancer detection tech developer Thrive Earlier Detection for $2.15 billion. Under the agreement, Thrive will receive the total consideration of up to $2.15 billion, which includes $1.7 billion payable at closing, comprised of 65% of Exact Sciences common stock and 35% in cash, according to a […]

Filed Under: Business/Financial News, Diagnostics, Featured, Mergers & Acquisitions, Oncology, Wall Street Beat Tagged With: Exact Sciences, Thrive Earlier Detection Corp.

Report: “Unglamorous” medtech outshines biopharma in 2019

July 31, 2019 By Nancy Crotti

Medtech merger and acquisition deal announcements slowed in the first half of 2019, but the industry got a boost from Verily’s $1 billion round of funding — the largest ever for a medtech firm. The Verily round was twice the size of the biggest-ever VC deal for a biotech company, according to the Vantage Half-Year […]

Filed Under: Blog, Business/Financial News, Featured, Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Abiomed, Danaher Corp., Dentsply Sirona, Evaluate Ltd., Exact Sciences, Siemens, Steris Corp., Straumann Holdings AG, Terumo, Verily

Exact Sciences is successful: Here are the secrets that helped it grow

May 31, 2019 By Chris Newmarker

Kevin Conroy knew he was taking a risk when he became CEO of Exact Sciences: The company had twice failed to develop screening tests for colorectal cancer, and it was light on cash. But as he explained in a recent LinkedIn blog post, he had three friends diagnosed with colorectal cancer around the same time: “While […]

Filed Under: Business/Financial News, Diagnostics, Featured, Wall Street Beat Tagged With: Exact Sciences, Medtech Conference

Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

January 18, 2018 By Chris Newmarker

Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader in consumable […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics Tagged With: Exact Sciences, Phillips-Medisize

Medtech stocks: the best and worst of Q1 2017

April 6, 2017 By Chris Newmarker

More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017, according to a Medical Design & Outsourcing analysis of how the stocks of our Big 100 companies are faring. The situation suggests that even with the uncertainty around what the […]

Filed Under: Business/Financial News, News Well, Wall Street Beat Tagged With: Analogic, CryoLife, Dexcom, Exact Sciences, integer, Invacare, Konica Minolta, Masimo, Terumo, wrightmedical

New blood-based test could detect all lung cancer types

March 7, 2017 By Danielle Kirsh

Exact Sciences and the Mayo Clinic recently collaborated on a blood-based lung cancer test that researchers say has shown high accuracy for detecting all stages of lung cancer. “These results reveal an opportunity to detect lung cancer from a simple blood draw,” said Kevin Conroy, chairman and CEO of Exact Sciences, in a news release. “Our […]

Filed Under: Biotech, Oncology, Research & Development Tagged With: American Association for Cancer Research, Cancer, Exact Sciences, lung cancer, Mayo Clinic, MedTech

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS